Granovsky Gluskin Orthopedic Division, Sinai Health System, University of Toronto, Toronto, ON, Canada.
Eur J Orthop Surg Traumatol. 2023 Oct;33(7):2943-2949. doi: 10.1007/s00590-023-03514-0. Epub 2023 Mar 13.
Studying long-term survivorship and functional outcomes for specific prostheses is critical for elucidating areas in need of design improvement. This study reports the long-term of the NexGen Posterior Stabilized (PS) Total Knee implant (TKA) (Zimmer Biomet, Warsaw IN) Performed by a single surgeon.
Data from patients treated with the NexGen PS TKA between January 2003 and December 2005 with a minimal follow-up of 15 years was collected from a prospectively collected database. Survivorship rates and Oxford Knee Scores (OKS) were obtained for those patients available for follow-up.
Ninety-five patients met the inclusion criteria during the study period. OKS was available for 44 (46%) patients. Ten patients required revision surgery (10.52%). Implant-specific survivorship of all cases that were reviewed was 98%. Survivorship of implants in patients that we were able to reach, or deceased patients was 93%. The average Oxford Knee Score was 39.1 (14-48. SD ± 7.70) with 48 being the maximal score.
Despite some concerns about durability of this implant, good longevity and function was demonstrated. At a minimum of 15 years follow-up in this cohort. Given these results design features of this system should be considered for future generations of implants.
研究特定假体的长期存活率和功能结果对于阐明需要改进设计的领域至关重要。本研究报告了由一位外科医生进行的 NexGen 后稳定(PS)全膝关节置换术(TKA)(捷迈邦美,印第安纳州华沙)的长期结果。
从 2003 年 1 月至 2005 年 12 月期间接受 NexGen PS TKA 治疗的患者中收集了前瞻性收集的数据库中至少随访 15 年的数据。对可随访的患者进行生存率和牛津膝关节评分(OKS)的评估。
在研究期间,有 95 名患者符合纳入标准。有 44 名(46%)患者提供了 OKS 评分。有 10 名患者需要进行翻修手术(10.52%)。所有接受评估的病例的特定假体生存率为 98%。我们能够联系到的患者或已故患者的假体生存率为 93%。平均牛津膝关节评分为 39.1(14-48,标准差±7.70),最大评分为 48。
尽管对这种假体的耐用性存在一些担忧,但在本队列中至少 15 年的随访中,证明了良好的长期生存率和功能。考虑到这些结果,应考虑将该系统的设计特点用于未来几代的植入物。